Clinical Trials Logo

Clinical Trial Summary

Six-years following participation in the Family Bereavement Program (FBP) participants in the program as compared to a self-study control group will have lower levels of mental health problems, lower one-year prevalence of mental disorder that meets diagnostic criteria, lower use of substances, higher levels of competence at achieving developmentally appropriate tasks in academic achievement and social competence, and better self-esteem. The effects of the FBP will be moderated by baseline levels of mental health problems and gender. Bereaved caregivers who participated in the program will also show lower levels of mental health problems as compared with controls.

Program effects will be mediated by theoretical mediators targeted by the program.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01008189
Study type Interventional
Source Arizona State University
Contact
Status Completed
Phase Phase 3
Start date January 1996
Completion date July 2009

See also
  Status Clinical Trial Phase
Completed NCT02415647 - Longitudinal Family/Molecular Genetic Study to Validate Research Domain Criteria
Completed NCT00001768 - Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg) Phase 3
Completed NCT01940978 - A Study of Combination Therapy in Children With ADHD Phase 4
Completed NCT00104039 - Brain Changes in Children and Adolescents With Behavioral Problems
Completed NCT00070876 - Psychosocial Training for Pediatric Health Care Providers N/A